A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea
Phase 4
Completed
- Conditions
- Gonorrhea
- Interventions
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 113
- Registration Number
- NCT04202068
PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)
Phase 4
Completed
- Conditions
- Respiratory Tract InfectionsUrinary Tract Infections in Children
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT04066621
Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Phase 4
- Conditions
- Respiratory Tract InfectionsUrinary Tract Infections
- Interventions
- Drug: xin te mie
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2013-07-12
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 2000
- Registration Number
- NCT01897831
Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection
Phase 4
Completed
- Conditions
- Respiratory Tract InfectionsUrinary Tract Infections
- Interventions
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 2000
- Registration Number
- NCT01760109
- Locations
- 🇨🇳
Chongqing Red Cross hospital, Chongqing, China
Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Phase 2
Suspended
- Conditions
- Respiratory Tract InfectionsUrinary Tract Infections
- Interventions
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 288
- Registration Number
- NCT01601093
- Locations
- 🇨🇳
the First Affiliated Hospital With Medical University, Nanjing, Jiangsu, China
Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Target Recruit Count
- 2032
- Registration Number
- NCT01426191
© Copyright 2025. All Rights Reserved by MedPath